InvestorsHub Logo
Followers 14
Posts 2307
Boards Moderated 0
Alias Born 01/02/2003

Re: None

Tuesday, 02/01/2022 9:34:41 PM

Tuesday, February 01, 2022 9:34:41 PM

Post# of 461361
Thanks to Missling for putting out the clarification...it answered my earlier question (directly/indirectly) about the change in phase 2 to 3 and change of the end point...

from the IBD article.

https://finance.yahoo.com/m/e06e7d2d-237e-359d-954b-618beecb551f/anavex-ceo-says-inaccurate.html


"The company also decided then to upgrade the study to a Phase 3 test based on confidence in earlier studies, Missling said. The new measures selected offer a better look at the drug's benefit, he said."


Straight from the horses mouth.

-vg_future
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News